AFT Pharmaceuticals Limited (AFT.NZ)

NZD 2.8

(0.0%)

Inventory Summary of AFT Pharmaceuticals Limited

AFT Pharmaceuticals Limited's latest annual inventory in 2024 was 49.05 Million NZD , up 15.71% from previous year.
AFT Pharmaceuticals Limited's latest quarterly inventory in 2024 FY was 49.05 Million NZD , up 15.71% from previous quarter.
AFT Pharmaceuticals Limited reported annual inventory of 42.39 Million NZD in 2023, up 26.56% from previous year.
AFT Pharmaceuticals Limited reported annual inventory of 33.5 Million NZD in 2022, down -0.46% from previous year.
AFT Pharmaceuticals Limited reported quarterly inventory of 49.05 Million NZD for 2024 Q3, down -10.23% from previous quarter.
AFT Pharmaceuticals Limited reported quarterly inventory of 54.64 Million NZD for 2024 Q1, up 28.9% from previous quarter.

Annual Inventory Chart of AFT Pharmaceuticals Limited (2024 - 2013)

Historical Annual Inventory of AFT Pharmaceuticals Limited (2024 - 2013)

Year	Inventory	Inventory Growth
2024	49.05 Million NZD	15.71%
2023	42.39 Million NZD	26.56%
2022	33.5 Million NZD	-0.46%
2021	33.65 Million NZD	48.03%
2020	22.73 Million NZD	-9.64%
2019	25.15 Million NZD	3.06%
2018	24.41 Million NZD	30.42%
2017	18.71 Million NZD	17.48%
2016	15.93 Million NZD	8.49%
2015	14.68 Million NZD	16.06%
2014	12.65 Million NZD	8.16%
2013	11.69 Million NZD	0.0%

Year	Inventory	Inventory Growth
2024 FY	49.05 Million NZD	15.71%
2024 Q3	49.05 Million NZD	-10.23%
2024 Q1	54.64 Million NZD	28.9%
2024 Q4	49.05 Million NZD	0.0%
2024 Q2	54.64 Million NZD	0.0%
2023 Q3	42.39 Million NZD	6.77%
2023 Q4	42.39 Million NZD	0.0%
2023 FY	42.39 Million NZD	26.56%
2023 Q1	39.7 Million NZD	18.53%
2023 Q2	39.7 Million NZD	0.0%
2022 Q1	34.12 Million NZD	1.41%
2022 Q4	33.5 Million NZD	0.0%
2022 Q3	33.5 Million NZD	-1.84%
2022 FY	33.5 Million NZD	-0.46%
2022 Q2	34.12 Million NZD	0.0%
2021 Q2	35.99 Million NZD	0.0%
2021 Q1	35.99 Million NZD	58.33%
2021 Q3	33.65 Million NZD	-6.5%
2021 Q4	33.65 Million NZD	0.0%
2021 FY	33.65 Million NZD	48.03%
2020 Q4	22.73 Million NZD	0.0%
2020 Q2	26.83 Million NZD	0.0%
2020 Q1	26.83 Million NZD	6.67%
2020 FY	22.73 Million NZD	-9.64%
2020 Q3	22.73 Million NZD	-15.28%
2019 Q4	25.15 Million NZD	0.0%
2019 FY	25.15 Million NZD	3.06%
2019 Q3	25.15 Million NZD	-9.55%
2019 Q2	27.81 Million NZD	0.0%
2019 Q1	27.81 Million NZD	13.94%
2018 Q1	21.13 Million NZD	12.92%
2018 Q4	24.41 Million NZD	0.0%
2018 Q3	24.41 Million NZD	15.49%
2018 Q2	21.13 Million NZD	0.0%
2018 FY	24.41 Million NZD	30.42%
2017 FY	18.71 Million NZD	17.48%
2017 Q2	21.45 Million NZD	0.0%
2017 Q1	21.45 Million NZD	21.29%
2017 Q3	22.19 Million NZD	3.48%
2017 Q4	18.71 Million NZD	-15.68%
2016 Q3	16.49 Million NZD	9.47%
2016 Q2	15.07 Million NZD	0.0%
2016 FY	15.93 Million NZD	8.49%
2016 Q4	17.68 Million NZD	7.19%
2016 Q1	15.07 Million NZD	2.63%
2015 Q4	14.68 Million NZD	0.0%
2015 Q1	- NZD	0.0%
2015 Q3	14.68 Million NZD	0.0%
2015 FY	14.68 Million NZD	16.06%
2014 FY	12.65 Million NZD	8.16%
2013 FY	11.69 Million NZD	0.0%

Peer Inventory Comparison of AFT Pharmaceuticals Limited

Name	Inventory	Inventory Difference
Greenfern Industries Limited	- NZD	-Infinity%
Rua Bioscience Limited	277.53 Thousand NZD	-17576.032%